Astrazeneca Pharma India Q1 FY19: Revenue ₹584.24 Cr
Q1 FY19 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #22 of 87 in Pharmaceuticals & Biotechnology
See the sector's top 10 — free with your mobile number.
Astrazeneca Pharma India Ltd Q1 FY19 key numbers
- Revenue
- Total revenue for AstraZeneca Pharma India Ltd (FY 2017-2018) reported as ₹584.24 Crore.
As stated in Astrazeneca Pharma India Ltd's Q1 FY19 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.
Based on Astrazeneca Pharma India Ltd's Q1 FY19 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Total revenue for AstraZeneca Pharma India Ltd (FY 2017-2018) reported as ₹584.24 Crore (Page 8).
From Astrazeneca Pharma India Ltd's Q1 FY19 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Total revenue for AstraZeneca Pharma India Ltd (FY 2017-2018) reported as ₹584.24 Crore (Page 8).
- Partner contribution to sales: ₹29.95 Crore (Page 8).
- The Indian Pharmaceutical Market (IPM) size is ₹127,253 Crore, poised to grow at ~10% over next four years (Page 6).
- AstraZeneca is one of the fastest-growing major MNCs in the IPM with 64% contribution from growth platforms (Page 8).
2 more points from Astrazeneca Pharma India Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Astrazeneca Pharma India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
See what Astrazeneca Pharma India Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Astrazeneca Pharma India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Astrazeneca Pharma India Ltd said on order book & pipeline — free account, 30 seconds.
Astrazeneca Pharma India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹729 Cr, net profit ₹62 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Astrazeneca Phar's management said in earlier quarters
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Astrazeneca Pharma India Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Astrazeneca Pharma India Ltd Q1 FY19 results?
Total revenue for AstraZeneca Pharma India Ltd (FY 2017-2018) reported as ₹584.24 Crore (Page 8).
What is Astrazeneca Pharma India Ltd share price analysis?
Astrazeneca Pharma India Ltd currently shows a neutral. The stock trades at a P/E of 97.3 with a market cap of ₹16,879 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Astrazeneca Pharma India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
